The global congestive heart failure treatment devices market size was US$ 12.57 billion in 2021. The global congestive heart failure treatment devices market size is forecast to reach US$ 20.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2022 to 2030.

A mechanical circulatory support device helps to treat congestive heart failure. Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter defibrillators, and ventricular assist devices are examples of congestive heart failure therapeutic equipment. Implantable cardiac defibrillators are electronic devices that are implanted into the body. An ICD (implantable cardiac defibrillator) continuously monitors heart rhythm and, if it becomes abnormal, delivers a mild shock to the heart muscle. A ventricular assist device aids in the pumping of blood from the heart's lower chambers to the rest of the body.

Factors Influencing Market Growth
The increasing prevalence of cardiovascular disorders, the growing risk of organ failure, and the expansion of new congestive heart failure treatment devices by many heart failure device companies drive the global market.
The increasing number of patients with heart failure has grown the demand for ventricular assist devices, boosting the global market growth.
The increasing geriatric population has led to an increase in the number of cardiovascular disease cases, and the growing shortage of organ donors fuels the global market growth.
The growing number of product approvals is forecast to offer lucrative opportunities for the global market during the forecast period.

Impact Analysis of COVID-19
The COVID-19 outbreak had a negative impact on the growth of the global market. Adult heart surgery volumes dropped dramatically during the first wave of the COVID-19 pandemic, as per the Society of Thoracic Surgeons. A COVID-19 pandemic has put a strain on the global healthcare system. Several clinics and hospitals worldwide had to reconfigure to boost hospital capacity for COVID-19 patients. As a result, many non-essential surgical procedures had to cancel worldwide.

Regional Insights
North America garnered the major market share in 2021 and is forecast to maintain its dominance during the forecast period. As a result of the growing prevalence of cardiovascular surgeries, rising approvals for ventricular assist products, the existence of key players, and expansion in technology for healthcare.

Leading Competitors
The leading prominent companies profiled in the global congestive heart failure treatment devices market are:
Abbot Laboratories
Abiomed Incorporated
Berlin Heart GmbH
Biotronik SE and Co. KG
Boston Scientific Corporation
Jarvik Heart Incorporated
Lepu Medical
Medtronic Plc
Microport Scientific Corporation
Osypka Medical GmbH
Other Prominent Players

Scope of the Report
The global congestive heart failure treatment devices market segmentation focuses on Product Type, End-user, and Region.
Segmentation based on Product Type
Pacemakers
Cardiac Resynchronization Therapy
Implantable Cardioverter Defibrillators
Ventricular Assist Devices
Segmentation based on End-user
Hospitals
Ambulatory Surgical Centers
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Congestive Heart Failure Treatment Devices Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Congestive Heart Failure Treatment Devices Market is projected to reach US$ 20.7 billion by end of 2030 from US$ 12.57 billion in 2021, at a CAGR of 5.7%
Meta Keywords: congestive heart failure treatment devices market Size, congestive heart failure treatment devices market share, congestive heart failure treatment devices market trend, congestive heart failure treatment devices market Forecast, congestive heart failure treatment devices market insight